Poor
Not Aligned
Patient Risk:
Moderate
Summary
Most provided claims cannot be evaluated against the supplied prescribing information because the prompt only includes Sections 1 and 14 (indication/clinical studies) and does not provide label text for safety, contraindications, dosing, interactions, monitoring, or other topics. As a result, many statements are unsupported by the provided label excerpts.
Category Scores
Accurate Statements
reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis
Section 1 (INDICATIONS AND USAGE) and consistent description of ischemic stroke/TIA population in Section 14 (CLINICAL STUDIES).
Unsupported Statements
Aspirin is a commonly used over-the-counter medication for pain relief and reducing inflammation.
Not supported by the provided label excerpts (Sections 1 and 14 only).
A person with a history of stomach ulcers should avoid taking aspirin or use it with caution under medical supervision.
Not supported by the provided label excerpts.
A person with a history of bleeding disorders should avoid taking aspirin or use it with caution under medical supervision.
Not supported by the provided label excerpts.
A person with a history of kidney disease should avoid taking aspirin or use it with caution under medical supervision.
Not supported by the provided label excerpts.
Aspirin can exacerbate stomach ulcers.
Not supported by the provided label excerpts.
Aspirin can exacerbate bleeding disorders.
Not supported by the provided label excerpts.
Aspirin can exacerbate kidney disease.
Not supported by the provided label excerpts.
Aspirin can interact with blood thinners.
Not supported by the provided label excerpts.
Taking aspirin with blood thinners can increase the risk of bleeding.
Not supported by the provided label excerpts.
Aspirin can interact with certain antibiotics.
Not supported by the provided label excerpts.
Taking aspirin with certain antibiotics can increase the risk of bleeding.
Not supported by the provided label excerpts.
Aspirin can interact with diabetes medications.
Not supported by the provided label excerpts.
Taking aspirin with diabetes medications can reduce the effectiveness of the medication.
Not supported by the provided label excerpts.
Taking aspirin with these medications can increase the risk of bleeding or reduce the effectiveness of the medication.
Not supported by the provided label excerpts.
To minimize risks associated with aspirin, follow label instructions carefully.
Not supported by the provided label excerpts.
To minimize risks associated with aspirin, start with a low dose (81 mg or 325 mg) and gradually increase as needed.
Not supported by the provided label excerpts and introduces dosing details (mg, titration) not present in Sections 1 and 14.
Aspirin should be taken with food to reduce stomach upset.
Not supported by the provided label excerpts.
Aspirin should not be taken for extended periods.
Not supported by the provided label excerpts.
Monitoring your blood pressure and kidney function while taking aspirin is recommended.
Not supported by the provided label excerpts.
Children under the age of 18 should not take aspirin due to the risk of Reye's syndrome.
Not supported by the provided label excerpts.
Reye's syndrome is a rare but serious condition.
Not supported by the provided label excerpts.
The elderly should use aspirin with caution.
Not supported by the provided label excerpts.
In elderly people, aspirin can interact with other medications.
Not supported by the provided label excerpts.
In elderly people, aspirin can increase the risk of bleeding.
Not supported by the provided label excerpts.
Aspirin is a generic medication.
Not supported by the provided label excerpts.
Aspirin's patent expired in 2007.
Not supported by the provided label excerpts.
Biosimilars such as acetylsalicylic acid (ASA) may offer a more cost-effective option without compromising efficacy.
Not supported by the provided label excerpts and makes product-class/cost claims not contained in Sections 1 and 14.
Contradictions
Important Omissions
Any label-supported dosing/administration, contraindications, warnings/precautions, drug interactions, monitoring, and specific population guidance from the prescribing information.
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
The majority of claims concern safety, contraindications, interactions, dosing, and monitoring, but none of that information is present in the supplied label excerpts (only Sections 1 and 14). This creates uncertainty about label alignment for risk-related statements.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Large portion of the provided claims are unsupported because the supplied prescribing information excerpts do not include the relevant sections (e.g., contraindications, warnings, interactions, dosing/administration, pediatric/elderly guidance).
Suggested Improvement
Limit statements to what is supported by the provided label excerpts (Section 1 indication and Section 14 clinical study population/outcomes), or provide the missing label sections needed to evaluate safety, dosing, interactions, and population-specific claims.